Abstract
An efficacy study of tadalafil (5 mg once daily) for treating erectile dysfunction included sexual satisfaction and psychosocial outcome measures such as Treatment satisfaction (THX) domain of Sexual Life Quality Questionnaire, Self-Esteem And Relationship (SEAR) questionnaire, Sexual Encounter Profile questions 4 (SEP4; hardness satisfaction) and 5 (SEP5; overall satisfaction), intercourse satisfaction (IS) and overall satisfaction (OS) domains of International Index of Erectile Function (IIEF), and partner SEP question 3 (pSEP3). After a 4-week run-in phase, participants were randomized to receive either tadalafil (N=264) or placebo (N=78) for 12 weeks. Participants and partners were more satisfied (THX) with tadalafil (75 and 73, respectively) than with placebo (51 and 55, respectively, P<0.001). Statistically significant improvements in sexual relationship, confidence, self-esteem and overall relationship (SEAR), in addition to IS, OS, SEP5 and pSEP3 for tadalafil compared with placebo (P<0.001) correlated with erectile function (EF) improvement (assessed by change from baseline in IIEF-EF score). Tadalafil significantly improved treatment and sexual satisfaction, while improving multiple outcomes measured by SEAR.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brock G, Chan J, Carrier S, Chan M, Salgado L, Klein AH et al. The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners. BJU Int 2007; 99: 376–382.
Neese LE, Schover LR, Klein EA, Zippe C, Kupelian PA . Finding help for sexual problems after prostate cancer treatment: a phone survey of men's and women's perspectives. Psychooncology 2003; 12: 463–473.
Norcross WA, Ramirez C, Palinkas LA . The influence of women on the health care-seeking behavior of men. J Fam Pract 1996; 43: 475–480.
Perelman MA . Sex coaching for physicians: combination treatment for patient and partner. Int J Impot Res 2003; 15 (Suppl 5): S67–S74.
National Institutes of Health. Impotence. NIH Consens Statement Online 7–9 December 1992; 10: 1–31. http://consensus.nih.gov/1992/1992Impotence091html.htm [Accessed 16 March 2009].
Althof SE, Eid JF, Talley DR, Brock GB, Dunn ME, Tomlin ME et al. Through the eyes of women: the partners' perspective on tadalafil. Urology 2006; 68: 631–655.
Rosen R, Goldstein I, Huang XY, Bangerter K, Taylor T . The Treatment Satisfaction Scale (TSS) is a sensitive measure of treatment effectiveness for both patients and partners: results of a randomized controlled trial with vardenafil. J Sex Med 2007; 4: 1009–1021.
Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I . Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med 2005; 2: 675–684.
Rubio-Aurioles E, Kim E, Rosen R, Porst H, Burns P, Zeigler H et al. Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily. J Sex Med 2009; 6: 1314–1323.
Wiegel M, Meston C, Rosen R . The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 31: 1–20.
Mulhall JP . Deciphering erectile dysfunction drug trials. J Urol 2003; 170: 353–358.
Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH . Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346–351.
Woodward JM, Hass SL, Woodward PJ . Reliability and validity of the sexual life quality questionnaire (SLQQ). Qual Life Res 2002; 11: 365–377.
Althof SE, O'Leary MP, Cappelleri JC, Crowley AR, Tseng LJ, Collins S . Impact of erectile dysfunction on confidence, self-esteem and relationship satisfaction after 9 months of sildenafil citrate treatment. J Urol 2006; 176: 2132–2137.
Cappelleri JC, Althof SE, O'Leary MP, Glina S, King R, Stecher VJ et al. Clinically meaningful improvement on the Self-Esteem And Relationship questionnaire in men with erectile dysfunction. Qual Life Res 2007; 16: 1203–1210.
Althof SE, Cappelleri JC, Shpilsky A, Stecher V, Diuguid C, Sweeney M et al. Treatment responsiveness of the Self-Esteem and Relationship questionnaire in erectile dysfunction. Urology 2003; 61: 888–892.
Cappelleri JC, Althof SE, Siegel RL, Shpilsky A, Bell SS, Duttagupta S . Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res 2004; 16: 30–38.
Rosen RC, Cappelleri JC, Gendrano N . The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002; 14: 226–244.
Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol 2006; 50: 351–359.
Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB . The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998; 60: 458–465.
Shabsigh R, Klein LT, Seidman S, Kaplan SA, Lehrhoff BJ, Ritter JS . Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998; 52: 848–852.
Althof SE, O' Leary MP, Cappelleri JC, Glina S, King R, Tseng LJ et al. US and International SEAR study group. Self-esteem, confidence, and relationships in men treated with sildenafil citrate for erectile dysfunction: results of two double-blind, placebo-controlled trials. J Gen Intern Med 2006; 21: 1069–1074.
Althof SE . Quality of life and erectile dysfunction. Urology 2002; 59: 803–810.
Goldstein I, Fisher WA, Sand M, Rosen RC, Mollen M, Brock G et al., Vardenafil Study Group. Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial. J Sex Med 2005; 2: 819–832.
Martin-Morales A, Haro JM, Beardsworth A, Bertsch J, Kontodimas S, EDOS Group. Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS). Eur Urol 2007; 51: 541–550.
Eardley I, Mirone V, Montorsi F, Ralph D, Kell P, Warner MR et al. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy. BJU Int 2005; 96: 1323–1332.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
Althof S . Sex therapy in the age of pharmacotherapy. Annu Rev Sex Res 2006; 17: 116–132.
Rajfer J, Aliott PJ, Steidle CP, Fitch 3rd WP, Zhao Y, Yu A . Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 2007; 19: 95–103.
Acknowledgements
This work was sponsored by Eli Lilly and Company, including assistance with manuscript preparation provided by Laura Bean Warner, i3 Statprobe.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seftel, A., Buvat, J., Althof, S. et al. Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily. Int J Impot Res 21, 240–248 (2009). https://doi.org/10.1038/ijir.2009.22
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2009.22
Keywords
This article is cited by
-
Relationship between erectile function and sexual self-confidence: a path analytic model in men being treated with tadalafil
International Journal of Impotence Research (2014)
-
Retrospective analysis of the efficacy and safety of once-daily tadalafil in patient subgroups: men with mild vs moderate ED and aged <50 vs ⩾50 years
International Journal of Impotence Research (2013)